Citi upgrades Progenics Pharmaceuticals Inc (Nasdaq: PGNX) from Sell to Hold.

Citi analyst says, "Given that we were ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE